Dr. Radhakrishnan Ramchandren, MD ...

Dr. Radhakrishnan Ramchandren, M.D.

Claim this profile

University of Tennessee

Studies Lymphoma
Studies Hodgkin's Lymphoma
7 reported clinical trials
13 drugs studied

Area of expertise

1Lymphoma
Radhakrishnan Ramchandren, M.D. has run 7 trials for Lymphoma. Some of their research focus areas include:
Stage I
Stage IV
Stage III
2Hodgkin's Lymphoma
Radhakrishnan Ramchandren, M.D. has run 3 trials for Hodgkin's Lymphoma. Some of their research focus areas include:
Stage I
Stage IV
Stage III

Affiliated Hospitals

Image of trial facility.
University Of Tennessee
Image of trial facility.
University Of Tennessee Medical Center Cancer Institute

Clinical Trials Radhakrishnan Ramchandren, M.D. is currently running

More about Radhakrishnan Ramchandren, M.D.

Clinical Trial Related3 years of experience running clinical trials · Led 7 trials as a Principal Investigator · 3 Active Clinical Trials
Treatments Radhakrishnan Ramchandren, M.D. has experience with
  • Brentuximab Vedotin
  • Doxorubicin
  • Lenalidomide
  • Rituximab
  • Dacarbazine
  • Nivolumab

Other Doctors you might be interested in

Frequently asked questions

Do I need insurance to participate in a trial?
What does Radhakrishnan Ramchandren, M.D. specialize in?
Is Radhakrishnan Ramchandren, M.D. currently recruiting for clinical trials?
Are there any treatments that Radhakrishnan Ramchandren, M.D. has studied deeply?
What is the best way to schedule an appointment with Radhakrishnan Ramchandren, M.D.?
What is the office address of Radhakrishnan Ramchandren, M.D.?
Is there any support for travel costs?
Unbiased ResultsWe believe in providing patients with all the options.
Your Data Stays Your DataWe only share your information with the clinical trials you're trying to access.
Verified Trials OnlyAll of our trials are run by licensed doctors, researchers, and healthcare companies.
Back to top
Terms of Service·Privacy Policy·Cookies·Security